查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
去細胞真皮基質(ADM)植入：全球和區域市場分析與預測(2024-2030)
市場調查報告書
商品編碼
1389928

去細胞真皮基質(ADM)植入：全球和區域市場分析與預測(2024-2030)

Acellular Dermal Matrix Implant Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2030
出版日期: 按訂單生產 | 出版商: BIS Research | 英文 | 商品交期: 7-10個工作天內

價格
簡介目錄

預計到2030年，全球去細胞真皮基質（ADM）植入市場規模將成長至超過 10 億美元。

該市場是由需要組織再生和重組的燒燙傷、傷口和感染疾病等慢性疾病日益流行所推動的。此外，對微創手術不斷成長的需求推動對 ADM植入的需求，因為植入可用於各種微創手術。

依類型來看，人類皮膚部門由於其生物相容性和低排斥風險預計將佔據最大佔有率。此外，從應用來看，由於ADM在整形外科領域的廣泛應用，預計整形外科部門將佔最大佔有率。此外，從地區來看，由於慢性病患病率高且醫療基礎設施發達，北美預計將佔據最大佔有率。同時，由於該地區對 ADM 的需求不斷增加，預計亞洲將成為成長最快的市場。

本報告調查了全球去細胞真皮基質（ADM）植入市場，並提供了市場背景和概述，分析了市場成長的各種影響因素、研發趨勢、法律制度、市場規模推移和預測，各種細分及地區/主要國家的詳細分析，競爭形勢，主要企業分析等彙整資訊。

目錄

第1章 市場：產業展望

  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
    • 價值鏈分析
    • 市場地圖
    • 價格預測
  • 研發回顧
    • 依國家和公司分類的專利申請趨勢
  • 監管狀況
  • 利害關係人分析
    • 使用案例
    • 最終用戶和購買標準
  • 市場動態概覽
    • 市場促進因素
    • 市場抑制因素
    • 市場機會
  • 新創資金籌措：摘要

第2章 去細胞真皮基質（ADM）植入市場：依應用分類

  • 使用分類
  • 應用概述
  • 整形外科
    • 乳房重建
    • 臉部重組
    • 腹部整形術
    • 其他
  • 婦科
    • 應力性尿失禁
    • 骨盆器官脫垂
    • 陰道瘻管重組
    • 其他
  • 其他
    • 創傷治療
    • 燒燙傷修復
    • 牙科
    • 整形外科

第3章 去細胞真皮基質（ADM）植入市場：依產品類型

  • 產品分類
  • 產品概要
  • 人的皮膚
    • 同種異體
    • 自體
  • 動物皮
    • 豬
    • 牛
    • 其他

第4章 去細胞真皮基質（ADM）植入市場：依地區

  • 區域概況
  • 促進因素/抑制因素
  • 北美洲
    • 市場
    • 目的
    • 產品
    • 依國家/地區
  • 歐洲
    • 市場
    • 目的
    • 產品
    • 依國家/地區
  • 亞太地區
    • 市場
    • 目的
    • 產品
    • 依國家/地區

第5章 市場：競爭形勢/公司簡介

  • 競爭形勢
  • 公司簡介
    • Zimmer Biomet
    • Allergan
    • Stryker
    • MTF Biologics
    • LifeNet Health
    • Integra LifeSciences
    • Medtronic
    • Arthrex
    • Straumann
    • Wright Medical Group
    • Hans Biomed
    • Xtant Medical

第6章 成長機會/建議

第7章 調查方法

簡介目錄
Product Code: BHM1583SA

The global acellular dermal matrix (ADM) implants market is expected to cross $1 billion by 2030. ADMs are scaffolds derived from animal or human skin that are used to regenerate and reinforce damaged tissues. They are commonly used in plastic surgery, gynecology, and other reconstructive procedures.

The global acellular dermal matrix (ADM) implants market is driven by the increasing prevalence of chronic conditions such as burns, wounds, and infections, which require tissue regeneration and reconstruction. Additionally, the growing demand for minimally invasive procedures is driving the demand for ADM implants, as they can be used in a variety of minimally invasive procedures.

The global acellular dermal matrix (ADM) implants market is segmented by type, application, and region. By type, the human skin segment is expected to hold the largest market share due to its biocompatibility and low risk of rejection. By application, the plastic surgery segment is expected to hold the largest market share due to the wide range of applications of ADMs in plastic surgery procedures.

North America is expected to hold the largest market share due to the high prevalence of chronic conditions and the well-developed healthcare infrastructure in the region. However, Asia is expected to be the fastest-growing market due to the increasing demand for ADMs in the region.

The ADM implants market is characterized by the presence of both large multinational corporations and smaller regional players.

Some of the key players in the market include:

  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • MiMedx Group, Inc.
  • LifeCell Corporation
  • AlloSource LLC

These companies are engaged in research and development to expand their product offerings and improve the performance of their ADMs. They are also actively pursuing strategic partnerships and acquisitions to expand their market reach and strengthen their competitive positions.

Table of Contents

1. Markets: Industry Outlook

  • 1.1. Trends: Current and Future Impact Assessment
  • 1.2. Supply Chain Overview
    • 1.2.1. Value chain Analysis
    • 1.2.2. Market Map
    • 1.2.3. Pricing Forecast
  • 1.3. R&D Review
    • 1.3.1. Patent Filing Trend by Country, by Company
  • 1.4. Regulatory Landscape
  • 1.5. Stakeholder Analysis
    • 1.5.1. Use Case
    • 1.5.2. End User and buying criteria
  • 1.6. Market Dynamics Overview
    • 1.6.1. Market Drivers
    • 1.6.2. Market Restraints
    • 1.6.3. Market Opportunities
  • 1.7. Startup Funding Summary

2. Acellular Dermal Matrix Implants Market by Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.3. Plastic Surgery
    • 2.3.1. Breast Reconstruction
    • 2.3.2. Facial Reconstruction
    • 2.3.3. Abdominoplasty
    • 2.3.4. Other
  • 2.4. Gynecology
    • 2.4.1. Stress Urinary Incontinence
    • 2.4.2. Pelvic Organ Prolapse
    • 2.4.3. Reconstruction of Vaginal Fistulas
    • 2.4.4. Other
  • 2.5. Others
    • 2.5.1. Wound Healing
    • 2.5.2. Burn Repair
    • 2.5.3. Dental Applications
    • 2.5.4. Orthopedic Applications

3. Acellular Dermal Matrix Implants Market by Product Type

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Human Skin
    • 3.3.1. Allogenic
      • 3.3.1.1. Dermal Matrix
      • 3.3.1.2. Fat Grafts
    • 3.3.2. Autologous
      • 3.3.2.1. Dermal Matrix
      • 3.3.2.2. Fat Grafts
  • 3.4. Animal Skin
    • 3.4.1. Porcine
    • 3.4.2. Bovine
    • 3.4.3. Other

4. Acellular Dermal Matrix Implants Market by Region

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints
  • 4.3. North America
    • 4.3.1. Markets
      • 4.3.1.1. Key Market Participants in North America
      • 4.3.1.2. Business Drivers
      • 4.3.1.3. Business Challenges
    • 4.3.2. Application
    • 4.3.3. Product
    • 4.3.4. North America by Country
      • 4.3.4.1. U.S.
      • 4.3.4.2. Canada
  • 4.4. Europe
    • 4.4.1. Markets
      • 4.4.1.1. Key Market Participants in Europe
      • 4.4.1.2. Business Drivers
      • 4.4.1.3. Business Challenges
    • 4.4.2. Application
    • 4.4.3. Product
    • 4.4.4. Europe by Country
      • 4.4.4.1. U.K.
      • 4.4.4.2. Germany
      • 4.4.4.3. France
  • 4.5. Asia-Pacific
    • 4.5.1. Markets
      • 4.5.1.1. Key Market Participants in Asia-Pacific
      • 4.5.1.2. Business Drivers
      • 4.5.1.3. Business Challenges
    • 4.5.2. Application
    • 4.5.3. Product
    • 4.5.4. Asia-Pacific by Country
      • 4.5.4.1. China
      • 4.5.4.2. Japan
      • 4.5.4.3. India

5. Markets - Competitive Landscape & Company Profiles

  • 5.1. Competitive Landscape
  • 5.2. Company Profiles
    • 5.2.1. Zimmer Biomet
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers /End-Users
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Market Share
      • 5.2.1.7. Analyst View
    • 5.2.2. Allergan
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers /End-Users
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Market Share
      • 5.2.2.7. Analyst View
    • 5.2.3. Stryker
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers /End-Users
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Market Share
      • 5.2.3.7. Analyst View
    • 5.2.4. MTF Biologics
      • 5.2.4.1. Company Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers /End-Users
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Market Share
      • 5.2.4.7. Analyst View
    • 5.2.5. LifeNet Health
      • 5.2.5.1. Company Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers /End-Users
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Market Share
      • 5.2.5.7. Analyst View
    • 5.2.6. Integra LifeSciences
      • 5.2.6.1. Company Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers /End-Users
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Market Share
      • 5.2.6.7. Analyst View
    • 5.2.7. Medtronic
      • 5.2.7.1. Company Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers /End-Users
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Market Share
      • 5.2.7.7. Analyst View
    • 5.2.8. Arthrex
      • 5.2.8.1. Company Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers /End-Users
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Market Share
      • 5.2.8.7. Analyst View
    • 5.2.9. Straumann
      • 5.2.9.1. Company Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers /End-Users
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Market Share
      • 5.2.9.7. Analyst View
    • 5.2.10. Wright Medical Group
      • 5.2.10.1. Company Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers /End-Users
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Market Share
      • 5.2.10.7. Analyst View
    • 5.2.11. Hans Biomed
      • 5.2.11.1. Company Overview
      • 5.2.11.2. Top Products / Product Portfolio
      • 5.2.11.3. Top Competitors
      • 5.2.11.4. Target Customers /End-Users
      • 5.2.11.5. Key Personnel
      • 5.2.11.6. Market Share
      • 5.2.11.7. Analyst View
    • 5.2.12. Xtant Medical
      • 5.2.12.1. Company Overview
      • 5.2.12.2. Top Products / Product Portfolio
      • 5.2.12.3. Top Competitors
      • 5.2.12.4. Target Customers /End-Users
      • 5.2.12.5. Key Personnel
      • 5.2.12.6. Market Share
      • 5.2.12.7. Analyst View

6. Growth Opportunities & Recommendations

7. Research Methodology